Bayer Yakuhin Ltd. Has Legionella Infection Indication Approved For Its New Quinolone Antibacterial Agent Ciproxan
2/27/2006 2:20:31 PM
Tokyo, Feb 27, 2006 (JCN) - Bayer Yakuhin announced on February 24 that it has obtained additional approval for Ciproxan Injection/Tablet, its proprietary new-quinolone agent, from the Ministry of Health, Labor and Welfare.
Ciproxan is now available in the treatment of infections caused by Legionella bacteria including Legionella pneumonia.
comments powered by